AstraZeneca Chooses Salesforce Agentforce to Transform Customer Engagement

AstraZeneca has announced its selection of Agentforce Life Sciences for Customer Engagement as its global platform to transform interactions with healthcare professionals (HCPs). By leveraging data and Artificial Intelligence (AI), the biopharmaceutical giant aims to foster stronger, more meaningful relationships with the medical community.

This strategic move aligns with AstraZeneca's commitment to pushing the boundaries of science and delivering life-changing medicines in key areas such as oncology, rare diseases, and cardiovascular, renal, and metabolic conditions.

Redefining Healthcare Engagement

With Agentforce Life Sciences, Salesforce, and AstraZeneca are opening a new era of intelligent engagement. The partnership allows teams to focus on strategic outcomes rather than administrative tasks, ensuring that every interaction with a healthcare professional is relevant and valuable.

Frank Defesche, Senior Vice President and General Manager of Life Sciences at Salesforce, stated: "This partnership with AstraZeneca represents a clear step towards creating intelligent and proactive customer engagement in the healthcare and scientific sector. Together, we will equip AstraZeneca teams with the latest technology to offer personalized interaction and accelerate the delivery of medicines that change the lives of patients worldwide."

A Unified Global Platform

Salesforce will support Agentforce 360 for Life Sciences as the comprehensive customer engagement solution for AstraZeneca. Key capabilities include:

• Medical-Commercial Coordination: Consolidating insights on healthcare professionals to create a unified context across different teams.
• Personalized Interaction: Expanding operations across key account teams, reimbursement, and field work with AI-driven recommendations on the best next actions. AstraZeneca will also coordinate and automate multi-channel digital campaigns based on customer preferences.
• Advanced Interoperability: Leveraging the Model Context Protocol (MCP) and MuleSoft Agent Fabric, AstraZeneca will coordinate actions between internal and external agents across field work, commercial operations, and different brands and regions. This enables human teams and AI agents to work together seamlessly.

Accelerating Innovation

The alliance is not just about operational efficiency; it is about patient impact. By integrating AI into engagement processes, AstraZeneca can better anticipate needs, optimize resources, and ultimately strengthen its ability to bring innovative treatments to patients faster.